Literature DB >> 17940137

Multisite and bidirectional exonic splicing enhancer in CD44 alternative exon v3.

Elena Vela1, Josep M Hilari, Xavier Roca, Ana M Muñoz-Mármol, Aurelio Ariza, Marcos Isamat.   

Abstract

The human CD44 gene encodes multiple isoforms of a transmembrane protein that differ in their extracellular domains as a result of alternative splicing of its variable exons. Expression of CD44 is tightly regulated according to the type and physiological status of a cell, with expression of high molecular weight isoforms by inclusion of variable exons and low molecular weight isoforms containing few or no variable exons. Human CD44 variable exon 3 (v3) can follow a specific alternative splicing route different from that affecting other variable exons. Here we map and functionally describe the splicing enhancer element within CD44 exon v3 which regulates its inclusion in the final mRNA. The v3 splicing enhancer is a multisite bipartite element consisting of a tandem nonamer, the XX motif, and an heptamer, the Y motif, located centrally in the exon. Each of the three sites of this multisite enhancer partially retains its splicing enhancing capacity independently from each other in CD44 and shows full enhancing function in gene contexts different from CD44. We further demonstrate that these motifs act cooperatively as at least two motifs are needed to maintain exon inclusion. Their action is differential with respect to the splice-site target abutting v3. The first X motif acts on the 3' splice site, the second X motif acts on both splice sites (as a bidirectional exonic splicing enhancer), and the Y motif acts on the 5' splice site. We also show that the multisite v3 splicing enhancer is functional irrespective of flanking intron length and spatial organization within v3.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940137      PMCID: PMC2080591          DOI: 10.1261/rna.732807

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  35 in total

Review 1.  Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions.

Authors:  J Bajorath
Journal:  Proteins       Date:  2000-05-01

Review 2.  Sorting out the complexity of SR protein functions.

Authors:  B R Graveley
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

3.  RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons.

Authors:  William G Fairbrother; Gene W Yeo; Rufang Yeh; Paul Goldstein; Matthew Mawson; Phillip A Sharp; Christopher B Burge
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

4.  Use of minigene systems to dissect alternative splicing elements.

Authors:  Thomas A Cooper
Journal:  Methods       Date:  2005-12       Impact factor: 3.608

5.  Comparative analysis identifies exonic splicing regulatory sequences--The complex definition of enhancers and silencers.

Authors:  Amir Goren; Oren Ram; Maayan Amit; Hadas Keren; Galit Lev-Maor; Ida Vig; Tal Pupko; Gil Ast
Journal:  Mol Cell       Date:  2006-06-23       Impact factor: 17.970

6.  Identification of novel splice variants of the human CD44 gene.

Authors:  Elena Vela; Xavier Roca; Marcos Isamat
Journal:  Biochem Biophys Res Commun       Date:  2006-03-02       Impact factor: 3.575

7.  A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family.

Authors:  I Stamenkovic; M Amiot; J M Pesando; B Seed
Journal:  Cell       Date:  1989-03-24       Impact factor: 41.582

8.  Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

Authors:  G R Screaton; M V Bell; D G Jackson; F B Cornelis; U Gerth; J I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  The role of exon sequences in splice site selection.

Authors:  A Watakabe; K Tanaka; Y Shimura
Journal:  Genes Dev       Date:  1993-03       Impact factor: 11.361

10.  Comprehensive splice-site analysis using comparative genomics.

Authors:  Nihar Sheth; Xavier Roca; Michelle L Hastings; Ted Roeder; Adrian R Krainer; Ravi Sachidanandam
Journal:  Nucleic Acids Res       Date:  2006-08-12       Impact factor: 16.971

View more
  3 in total

1.  Transposable elements in disease-associated cryptic exons.

Authors:  Igor Vorechovsky
Journal:  Hum Genet       Date:  2009-10-10       Impact factor: 4.132

2.  Conservation of CD44 exon v3 functional elements in mammals.

Authors:  Elena Vela; Josep M Hilari; María Delclaux; Hugo Fernández-Bellon; Marcos Isamat
Journal:  BMC Res Notes       Date:  2008-07-29

Review 3.  The spliceosome as target for anticancer treatment.

Authors:  R J van Alphen; E A C Wiemer; H Burger; F A L M Eskens
Journal:  Br J Cancer       Date:  2008-11-25       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.